Literature DB >> 15193737

LC-MS determination of desmopressin acetate in human skin samples.

Melkamu Getie1, Reinhard H H Neubert.   

Abstract

A sensitive, selective and accurate high-performance liquid chromatography-mass spectroscopy (LC-MS) assay for the determination of desmopressin acetate (1-deamino-8-D-arginine vasopressin, DDAVP) from human skin samples was developed and validated. Pieces of human breast skin were impregnated with DDAVP solutions and DDAVP was extracted with an optimum extraction procedure. The extracted solutions were then analyzed by a LC system, comprising of a Nucleosil C18 column (CC 125/2, 120-3) and a mobile phase of 0.01% formic acid in a mixture of 1.6 mM ammonium acetate and acetonitrile (33:67, v/v), coupled with electrospray ionization mass spectrometry (ESI-MS). Satisfactory results were obtained with limits of detection and quantification as low as 10 and 40 ng/ml, respectively, and with very good intra- and inter-day repeatability. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193737     DOI: 10.1016/j.jpba.2004.02.009

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats.

Authors:  Keizo Fukushima; Ayaka Ise; Hiromi Morita; Ryo Hasegawa; Yukako Ito; Nobuyuki Sugioka; Kanji Takada
Journal:  Pharm Res       Date:  2010-03-19       Impact factor: 4.200

2.  Development and Validation of a Reversed-Phase High-performance Liquid Chromatography Method for Determination of Desmopressin in Chitosan Nanoparticles.

Authors:  S M Taghizadeh; F Mohamadnia; L Adlnasab
Journal:  Indian J Pharm Sci       Date:  2013-03       Impact factor: 0.975

3.  Highly sensitive assay for the determination of therapeutic peptide desmopressin in human plasma by UPLC-MS/MS.

Authors:  Shiva Kumar Gudlawar; Nageswara Rao Pilli; Sridhar Siddiraju; Jaya Dwivedi
Journal:  J Pharm Anal       Date:  2013-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.